Feedback

Editorial: Liver diseases and programmed cell death

Affiliation
Department of Pharmacy ,Union Hospital ,Tongji Medical College ,Huazhong University of Science and Technology ,Wuhan ,China
Cao, Peng;
Affiliation
The First Clinical College ,Guangdong Medical University ,Zhanjiang ,China
Liang, Yongyi;
Affiliation
Department of Critical Care Medicine ,Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital ,Chengdu ,China
Wang, Yi;
Affiliation
Department of Experimental Radiation Oncology ,The University of Texas MD Anderson Cancer Center ,Houston ,TX ,United States
Mao, Chao;
Affiliation
State Key Laboratory of Cellular Stress Biology ,School of Life Sciences ,Xiamen University ,Xiamen ,Fujian ,China
Wang, Weijia;
Affiliation
School of Public Health ,Shanghai Jiao Tong University ,Shanghai ,China
Li, Sha;
Affiliation
The Marine Biomedical Research Institute ,Guangdong Medical University ,Zhanjiang ,China
Luo, Lianxiang

Preview

Category

Published in:
Frontiers in Pharmacology  
Vol. 14 (28.03.2023)
Volume:
14
Date Issued:
28.03.2023
DOI:
10.3389/fphar.2023.1182013
Language:
English
Type of Resource:
Text
Keywords:
non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; alcohol-related liver disease; drug induced liver injury; hepatocellular carcinoma; programmed cell death
DDC subject of DNB:
610 Medical sciences Medicine

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:
open graphic

Rights

License Holder: Copyright © 2023 Cao, Liang, Wang, Mao, Wang, Li and Luo.

Use and reproduction: